Skip to content

Clinical trials

Phase 3 Hypertension trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Country / region: Australia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20083
20121
20171
20182
20192
20201
20214
20221
20233
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Recruiting3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Boehringer Ingelheim3
The George Institute3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
George Medicines PTY Limited2
Gilead Sciences2
Mineralys Therapeutics Inc.2
United Therapeutics2
Alnylam Pharmaceuticals1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension28
Cardiovascular Diseases5
Pulmonary Arterial Hypertension4
Renal Insufficiency, Chronic3
Cerebral Hemorrhage2
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Hemorrhagic Stroke2
Hypertension, Pulmonary2
Ischemic Stroke2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.